Literature DB >> 33694036

Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.

Sarah Soueges1, Claire Triffault-Fillit1, Sandrine Roux1, Hélène Labussière-Wallet2, David Lebeaux3,4, Oana Dumitrescu5,6, Isabelle Morelec7, Elisabeth Hodille6, Florence Ader8,9.   

Abstract

Nocardiosis is a life-threatening opportunistic infection in immunocompromised patients. Herein, we present successful adjunctive use of liposomal nebulized amikacin and tedizolid in a recipient of allogeneic hematopoietic stem cell transplantation infected with Nocardia nova complex who presented multiple complications to conventional therapeutic options.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Liposomal nebulized amikacin; Nocardiosis; Tedizolid

Year:  2021        PMID： 33694036     DOI： 10.1007/s10096-021-04186-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  12 in total

1.  Direct detection of Nocardia spp. in clinical samples by a rapid molecular method.

Authors:  Andrée Couble; Verónica Rodríguez-Nava; Michèle Pérouse de Montclos; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 2.  Inhaled antibiotics for lower airway infections.

Authors:  Bradley S Quon; Christopher H Goss; Bonnie W Ramsey
Journal:  Ann Am Thorac Soc       Date:  2014-03

3.  Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

Authors:  Lisa R McTaggart; Jennifer Doucet; Maria Witkowska; Susan E Richardson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 4.  Deposition of aerosol in the respiratory tract.

Authors:  J D Brain; P A Valberg
Journal:  Am Rev Respir Dis       Date:  1979-12

5.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

7.  Experimental Granulomatous Pulmonary Nocardiosis in BALB/C Mice.

Authors:  Roque M Mifuji Lira; Alberto Yairh Limón Flores; Mario César Salinas Carmona; Alejandro Ortiz Stern
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

8.  Linezolid Inhibited Synthesis of ATP in Mitochondria: Based on GC-MS Metabolomics and HPLC Method.

Authors:  Xuemei Ye; Aifang Huang; Xianqin Wang; Congcong Wen; Lufeng Hu; Guanyang Lin
Journal:  Biomed Res Int       Date:  2018-10-16       Impact factor: 3.411

Review 9.  Nocardiosis in transplant recipients.

Authors:  D Lebeaux; E Morelon; F Suarez; F Lanternier; A Scemla; P Frange; J-L Mainardi; M Lecuit; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-23       Impact factor: 5.103

10.  Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.

Authors:  Jimin Zhang; Franziska Leifer; Sasha Rose; Dung Yu Chun; Jill Thaisz; Tracey Herr; Mary Nashed; Jayanthi Joseph; Walter R Perkins; Keith DiPetrillo
Journal:  Front Microbiol       Date:  2018-05-16       Impact factor: 5.640
View more
  1 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Tedizolid.

Authors:  Khalid Iqbal; Aliki Milioudi; Sebastian Georg Wicha
Journal:  Clin Pharmacokinet       Date:  2022-02-07       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.